α-Bisabolol Attenuates NF-κB/MAPK Signaling Activation and ER-Stress-Mediated Apoptosis by Invoking Nrf2-Mediated Antioxidant Defense Systems against Doxorubicin-Induced Testicular Toxicity in Rats
Open Access
Abstract
The present study investigated the effects of α-bisabolol on DOX-induced testicular damage in rats. Testicular damage was induced in rats by injecting DOX (12.5 mg/kg, i.p., single dose) into rats. α-Bisabolol (25 mg/kg, i.p.) was administered to the rats along with DOX pre- and co-treatment daily for a period of 5 days. DOX-injected rats showed a decrease in absolute testicular weight and relative testicular weight ratio along with concomitant changes in the levels/expression levels of oxidative stress markers and Nrf2 expression levels in the testis. DOX injection also triggered the activation of NF-κB/MAPK signaling and increased levels/expression levels of pro-inflammatory cytokines (TNF-α, IL-6, and IL-1β) and inflammatory mediators (iNOS and COX-2) in the testis. DOX triggered apoptosis, manifested by an increment in the expression levels of pro-apoptotic markers (Bax, Bcl2, cleaved caspase-3 and -9, and cytochrome-C) and a decline in the expression levels of anti-apoptotic markers (Bcl-xL and Bcl2) in the testis. Additionally, light microscopy revealed the changes in testicular architecture. α-Bisabolol rescued alterations in the testicular weight; restored all biochemical markers; modulated the expression levels of Nrf2-mediated antioxidant responses, NF-κB/MAPK signaling, endoplasmic reticulum (ER) stress, and apoptosis markers in DOX-injected testicular toxicity in rats. Based on our findings, it can be concluded that α-bisabolol has the potential to attenuate DOX-induced testicular injury by modifying NF-κB/MAPK signaling and the ER-stress-mediated mitochondrial pathway of apoptosis by invoking Nrf2-dependent antioxidant defense systems in rats. Based on the findings of the present study, α-bisabolol could be suggested for use as an agent or adjuvant with chemotherapeutic drugs to attenuate their deleterious effects of DOX on many organs including the testis. However, further regulatory toxicology and preclinical studies are necessary before making recommendations in clinical tests.Keywords
Funding Information
- United Arab Emirates University (# 12R121 and 12R104)
This publication has 65 references indexed in Scilit:
- Doxorubicin Induces Cytotoxicity through Upregulation of pERK–Dependent ATF3PLOS ONE, 2012
- Antitumor effects of α‐bisabolol against pancreatic cancerCancer Science, 2011
- Doxorubicin Induced Nephrotoxicity: Protective Effect of NicotinamideInternational Journal of Cell Biology, 2011
- Doxorubicin pathwaysPharmacogenetics and Genomics, 2011
- Content and composition of the essential oil ofChamomilla recutita(L.) Rauschert from some European countriesNatural Product Research, 2010
- American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer PatientsJournal of Clinical Oncology, 2006
- Lycopene prevents adriamycin-induced testicular toxicity in ratsFertility and Sterility, 2006
- Lipoic acid ameliorates adriamycin-induced testicular mitochondriopathyReproductive Toxicology, 2005
- IκB kinases: key regulators of the NF-κB pathwayTrends in Biochemical Sciences, 2004
- Final Report on the Safety Assessment of Arnica Montana Extract and Arnica MontanaInternational Journal of Toxicology, 2001